{"id":44,"date":"2024-07-25T06:15:50","date_gmt":"2024-07-25T06:15:50","guid":{"rendered":"https:\/\/brigit.co.id\/?page_id=44"},"modified":"2025-04-09T04:22:24","modified_gmt":"2025-04-09T04:22:24","slug":"financial-statement","status":"publish","type":"page","link":"https:\/\/brigit.co.id\/zh\/financial-statement\/","title":{"rendered":"\u5e74\u5ea6\u62a5\u544a"},"content":{"rendered":"
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Ikhtisar Keuangan<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Ikhtisar Keuangan<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Tabel berikut ini menggambarkan ikhtisar data keuangan penting Konsolidasian Perseroan yang angka-angkanya diambil dari Laporan Keuangan Perseroan untuk periode 6 (enam) bulan yang berakhir pada tanggal 30 Juni 2024 dan tahun-tahun yang berakhir pada 31 Desember 2023, 31 Desember 2022 dan 31 Desember 2021<\/span><\/p>

Laporan keuangan untuk 6 (enam) bulan yang berakhir pada tanggal 30 Juni 2024 dan untuk tahun yang berakhir pada tanggal 31 Desember 2023, 31 Desember 2022, dan 31 Desember 2021 telah diaudit oleh Kantor Akuntan Publik Robert, Rudi, Yansen dan Rekan yang ditandatangani oleh Rudi M Tambunan, CA, CPA dengan opini tanpa modifikasian tanggal 10 Desember 2024.<\/p>

\u00a0<\/p>

Laporan keuangan Perseroan disusun berdasarkan Pernyataan Standar Akuntansi Keuangan yang dikeluarkan oleh Institut Akuntan Publik Indonesia yang merupakan standar akuntansi yang berlaku umum di Indonesia.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

Laporan Posisi Keuangan Konsolidasian<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Laporan Laba Rugi<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Rasio-Rasio Penting<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Rasio keuangan lain yang relevan dengan Perseroan di bidang manufaktur :<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Rasio keuangan yang dipersyaratkan oleh PT Bank Syariah Indonesia Tbk atas fasilitas pinjaman Entitas Induk,\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 PT Brigit Biofarmaka Teknologi sesuai dengan Akad Pembiayaan Mudharabah No. 161 tanggal 31 Agustus 2023 berdasarkan pada Surat Penawaran Pemberian Pembiayaan No. 03\/064-3\/0013A\/SP3 sebagai berikut:<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

\u8d22\u52a1\u62a5\u544a<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

LAPORAN KEUANGAN AUDITAN PT BRIGIT BIOFARMAKA TEKNOLOGI Tbk per 31 Desember 2024<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\u4e0b\u8f7dPDF<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

LAPORAN KEUANGAN AUDITAN PT BRIGIT BIOFARMAKA TEKNOLOGI Tbk Q2 2024

ANNUAL REPORT 2024 OBAT<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\u4e0b\u8f7dPDF<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\u4e0b\u8f7dPDF<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

Ikhtisar Keuangan Ikhtisar Keuangan Tabel berikut ini menggambarkan ikhtisar data keuangan penting Konsolidasian Perseroan yang angka-angkanya diambil dari Laporan Keuangan Perseroan untuk periode 6 (enam) bulan yang berakhir pada tanggal 30 Juni 2024 dan tahun-tahun yang berakhir pada 31 Desember 2023, 31 Desember 2022 dan 31 Desember 2021 Laporan keuangan untuk 6 (enam) bulan yang berakhir pada tanggal 30 Juni 2024 dan untuk tahun yang berakhir pada tanggal 31 Desember 2023, 31 Desember 2022, dan 31 Desember 2021 telah diaudit oleh Kantor Akuntan Publik Robert, Rudi, Yansen dan Rekan yang ditandatangani oleh Rudi M Tambunan, CA, CPA dengan opini tanpa modifikasian tanggal 10 Desember 2024. \u00a0 Laporan keuangan Perseroan disusun berdasarkan Pernyataan Standar Akuntansi Keuangan yang dikeluarkan oleh Institut Akuntan Publik Indonesia yang merupakan standar akuntansi yang berlaku umum di Indonesia. Laporan Posisi Keuangan Konsolidasian Laporan Laba Rugi Rasio-Rasio Penting Rasio keuangan lain yang relevan dengan Perseroan di bidang manufaktur : Rasio keuangan yang dipersyaratkan oleh PT Bank Syariah Indonesia Tbk atas fasilitas pinjaman Entitas Induk,\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 PT Brigit Biofarmaka Teknologi sesuai dengan Akad Pembiayaan Mudharabah No. 161 tanggal 31 Agustus 2023 berdasarkan pada Surat Penawaran Pemberian Pembiayaan No. 03\/064-3\/0013A\/SP3 sebagai berikut: Laporan Keuangan LAPORAN KEUANGAN AUDITAN PT BRIGIT BIOFARMAKA TEKNOLOGI Tbk per 31 Desember 2024 Unduh PDF LAPORAN KEUANGAN AUDITAN PT BRIGIT BIOFARMAKA TEKNOLOGI Tbk Q2 2024 ANNUAL REPORT 2024 OBAT Unduh PDF Unduh PDF<\/p>","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"","ast-site-content-layout":"full-width-container","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-44","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/brigit.co.id\/zh\/wp-json\/wp\/v2\/pages\/44","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brigit.co.id\/zh\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/brigit.co.id\/zh\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/brigit.co.id\/zh\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/brigit.co.id\/zh\/wp-json\/wp\/v2\/comments?post=44"}],"version-history":[{"count":38,"href":"https:\/\/brigit.co.id\/zh\/wp-json\/wp\/v2\/pages\/44\/revisions"}],"predecessor-version":[{"id":3680,"href":"https:\/\/brigit.co.id\/zh\/wp-json\/wp\/v2\/pages\/44\/revisions\/3680"}],"wp:attachment":[{"href":"https:\/\/brigit.co.id\/zh\/wp-json\/wp\/v2\/media?parent=44"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}